Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 28,647

Sort by:

Dental Caries (Mouth And Dental Disorders) - Drugs in Development, 2021

US$ 2,000.00

Dental Caries (Mouth And Dental Disorders) - Drugs in Development, 2021 SUMMARY Dental Caries (Mouth And Dental Disorders) - Drugs in Development, 2021 provides an overview of the Dental Caries pipeli...

April 2021 30 pages

Dental Pain (Toothache/Tooth Pain) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Dental Pain (Toothache/Tooth Pain) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Dental Pain (Toothache/Tooth Pain) (Central Nervous System) - Drugs in Development, 2021 provides an ov...

April 2021 35 pages

Dermatitis (Eczema) (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Dermatitis (Eczema) (Dermatology) - Drugs in Development, 2021 SUMMARY Dermatitis (Eczema) (Dermatology) - Drugs in Development, 2021 provides an overview of the Dermatitis (Eczema) pipeline landscape...

April 2021 55 pages

Dermatological Disorders (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Dermatological Disorders (Dermatology) - Drugs in Development, 2021 SUMMARY Dermatological Disorders (Dermatology) - Drugs in Development, 2021 provides an overview of the Dermatological Disorders pip...

April 2021 70 pages

Diabetic Complications (Metabolic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Diabetic Complications (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Diabetic Complications (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Diabetic Complic...

April 2021 50 pages

Diabetic Neuropathic Foot Ulcers (Metabolic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Diabetic Neuropathic Foot Ulcers (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Diabetic Neuropathic Foot Ulcers (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of...

April 2021 30 pages

Diabetic Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Diabetic Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021 SUMMARY Diabetic Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Diab...

April 2021 80 pages

Diastolic Heart Failure (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Diastolic Heart Failure (Cardiovascular) - Drugs in Development, 2021 SUMMARY Diastolic Heart Failure (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Diastolic Heart Failure...

April 2021 65 pages

Dihydrofolate Reductase (DHFR or EC 1.5.1.3) - Drugs in Development, 2021

US$ 3,000.00

Dihydrofolate Reductase (DHFR or EC 1.5.1.3) - Drugs in Development, 2021 SUMMARY Dihydrofolate Reductase (DHFR or EC 1.5.1.3) - Drugs in Development, 2021 provides in depth analysis on Dihydrofolate...

April 2021 50 pages

Dihydroorotate Dehydrogenase (Quinone) Mitochondrial (Dihydroorotate Oxidase or DHODH or EC 1.3.5.2) - Drugs in Development, 2021

US$ 3,000.00

Dihydroorotate Dehydrogenase (Quinone) Mitochondrial (Dihydroorotate Oxidase or DHODH or EC 1.3.5.2) - Drugs in Development, 2021 SUMMARY Dihydroorotate Dehydrogenase (Quinone) Mitochondrial (Dihydroo...

April 2021 45 pages

DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,000.00

DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or...

April 2021 35 pages

DNA Directed RNA Polymerase (POLR2 or EC 2.7.7.6) - Drugs in Development, 2021

US$ 3,000.00

DNA Directed RNA Polymerase (POLR2 or EC 2.7.7.6) - Drugs in Development, 2021 SUMMARY DNA Directed RNA Polymerase (POLR2 or EC 2.7.7.6) - Drugs in Development, 2021 provides in depth analysis on DNA...

April 2021 35 pages

DNA Repair Protein RAD51 Homolog 1 (RAD51 Homolog A or RAD51) - Drugs in Development, 2021

US$ 3,000.00

DNA Repair Protein RAD51 Homolog 1 (RAD51 Homolog A or RAD51) - Drugs in Development, 2021 SUMMARY DNA Repair Protein RAD51 Homolog 1 (RAD51 Homolog A or RAD51) - Drugs in Development, 2021 provides i...

April 2021 30 pages

DNA Topoisomerase I (TOP1 or EC 5.99.1.2) - Drugs in Development, 2021

US$ 3,000.00

DNA Topoisomerase I (TOP1 or EC 5.99.1.2) - Drugs in Development, 2021 SUMMARY DNA Topoisomerase I (TOP1 or EC 5.99.1.2) - Drugs in Development, 2021 provides in depth analysis on DNA Topoisomerase I...

April 2021 105 pages

DNA Topoisomerase II (EC 5.99.1.3) - Drugs in Development, 2021

US$ 3,000.00

DNA Topoisomerase II (EC 5.99.1.3) - Drugs in Development, 2021 SUMMARY DNA Topoisomerase II (EC 5.99.1.3) - Drugs in Development, 2021 provides in depth analysis on DNA Topoisomerase II (EC 5.99.1.3)...

April 2021 130 pages

DNA Topoisomerase IV (EC 5.99.1.3) - Drugs in Development, 2021

US$ 3,000.00

DNA Topoisomerase IV (EC 5.99.1.3) - Drugs in Development, 2021 SUMMARY DNA Topoisomerase IV (EC 5.99.1.3) - Drugs in Development, 2021 provides in depth analysis on DNA Topoisomerase IV (EC 5.99.1.3)...

April 2021 80 pages

Double Homeobox Protein 4 (Double Homeobox Protein 10 or DUX4) - Drugs in Development, 2021

US$ 3,000.00

Double Homeobox Protein 4 (Double Homeobox Protein 10 or DUX4) - Drugs in Development, 2021 SUMMARY Double Homeobox Protein 4 (Double Homeobox Protein 10 or DUX4) - Drugs in Development, 2021 provides...

April 2021 35 pages

Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) (Central Nervous System) - D...

April 2021 65 pages

Drug-Induced Dyskinesia (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Drug-Induced Dyskinesia (Central Nervous System) - Drugs in Development, 2021 SUMMARY Drug-Induced Dyskinesia (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Drug-Ind...

April 2021 50 pages

Drug Toxicity (Toxicology) - Drugs in Development, 2021

US$ 2,000.00

Drug Toxicity (Toxicology) - Drugs in Development, 2021 SUMMARY Drug Toxicity (Toxicology) - Drugs in Development, 2021 provides an overview of the Drug Toxicity pipeline landscape. The report provide...

April 2021 45 pages

Dry (Atrophic) Macular Degeneration (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Dry (Atrophic) Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 SUMMARY Dry (Atrophic) Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Dr...

April 2021 110 pages

Dual Specificity Mitogen Activated Protein Kinase Kinase 1 (ERK Activator Kinase 1 or MAPK/ERK Kinase 1 or MAP2K1 or EC 2.7.12.2) - Drugs in Development, 2021

US$ 3,000.00

Dual Specificity Mitogen Activated Protein Kinase Kinase 1 (ERK Activator Kinase 1 or MAPK/ERK Kinase 1 or MAP2K1 or EC 2.7.12.2) - Drugs in Development, 2021 SUMMARY Dual Specificity Mitogen Activate...

April 2021 60 pages

Dual Specificity Mitogen Activated Protein Kinase Kinase 2 (ERK Activator Kinase 2 or MAPK/ERK Kinase 2 or MAP2K2 or EC 2.7.12.2) - Drugs in Development, 2021

US$ 3,000.00

Dual Specificity Mitogen Activated Protein Kinase Kinase 2 (ERK Activator Kinase 2 or MAPK/ERK Kinase 2 or MAP2K2 or EC 2.7.12.2) - Drugs in Development, 2021 SUMMARY Dual Specificity Mitogen Activate...

April 2021 55 pages

Ductal Carcinoma In Situ (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Ductal Carcinoma In Situ (Oncology) - Drugs in Development, 2021 SUMMARY Ductal Carcinoma In Situ (Oncology) - Drugs in Development, 2021 provides an overview of the Ductal Carcinoma In Situ pipeline...

April 2021 30 pages

Duodenal Ulcer (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Duodenal Ulcer (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Duodenal Ulcer (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Duodenal Ulcer pipeline landscape. The...

April 2021 40 pages

Dystonia (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Dystonia (Central Nervous System) - Drugs in Development, 2021 SUMMARY Dystonia (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Dystonia pipeline landscape. The repor...

April 2021 35 pages

Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 1 (Membrane Component Chromosome 6 Surface Marker 1 or Phosphodiesterase I/Nucleotide Pyrophosphatase 1 or Plasma Cell Membrane Glycoprotein PC1 or ENPP1 or EC 3.1.4.1 or EC 3.6.1.9) - Drugs in Development, 2021

US$ 3,000.00

Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 1 (Membrane Component Chromosome 6 Surface Marker 1 or Phosphodiesterase I/Nucleotide Pyrophosphatase 1 or Plasma Cell Membrane Glycoprot...

April 2021 30 pages

Edema (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Edema (Cardiovascular) - Drugs in Development, 2021 SUMMARY Edema (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Edema pipeline landscape. The report provides comprehensive...

April 2021 35 pages

Emesis (Vomiting) (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Emesis (Vomiting) (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Emesis (Vomiting) (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Emesis (Vomiting) pipeline lands...

April 2021 45 pages

Emphysema (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Emphysema (Respiratory) - Drugs in Development, 2021 SUMMARY Emphysema (Respiratory) - Drugs in Development, 2021 provides an overview of the Emphysema pipeline landscape. The report provides comprehe...

April 2021 45 pages

Endocarditis (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Endocarditis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Endocarditis (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Endocarditis pipeline landscape. The report pr...

April 2021 30 pages

Endocrine Gland Disorders (Hormonal Disorders) - Drugs in Development, 2021

US$ 2,000.00

Endocrine Gland Disorders (Hormonal Disorders) - Drugs in Development, 2021 SUMMARY Endocrine Gland Disorders (Hormonal Disorders) - Drugs in Development, 2021 provides an overview of the Endocrine Gl...

April 2021 50 pages

Endothelin 1 Receptor (Endothelin A Receptor or EDNRA) - Drugs in Development, 2021

US$ 3,000.00

Endothelin 1 Receptor (Endothelin A Receptor or EDNRA) - Drugs in Development, 2021 SUMMARY Endothelin 1 Receptor (Endothelin A Receptor or EDNRA) - Drugs in Development, 2021 provides in depth analys...

April 2021 40 pages

Endothelin B Receptor (Endothelin Receptor Non Selective Type or EDNRB) - Drugs in Development, 2021

US$ 3,000.00

Endothelin B Receptor (Endothelin Receptor Non Selective Type or EDNRB) - Drugs in Development, 2021 SUMMARY Endothelin B Receptor (Endothelin Receptor Non Selective Type or EDNRB) - Drugs in Developm...

April 2021 35 pages

Endotoxemia (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Endotoxemia (Infectious Disease) - Drugs in Development, 2021 SUMMARY Endotoxemia (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Endotoxemia pipeline landscape. The repo...

April 2021 35 pages

Enoyl [Acyl Carrier Protein] Reductase [NADH] FabI (NADH Dependent Enoyl ACP Reductase or Enoyl ACP Reductase or EC 1.3.1.9) - Drugs in Development, 2021

US$ 3,000.00

Enoyl [Acyl Carrier Protein] Reductase [NADH] FabI (NADH Dependent Enoyl ACP Reductase or Enoyl ACP Reductase or EC 1.3.1.9) - Drugs in Development, 2021 SUMMARY Enoyl [Acyl Carrier Protein] Reductase...

April 2021 45 pages

Enoyl [Acyl Carrier Protein] Reductase [NADH] (FAS-II Enoyl ACP Reductase or NADH Dependent 2-Trans-Enoyl ACP Reductase or inhA or EC 1.3.1.9) - Drugs in Development, 2021

US$ 3,000.00

Enoyl [Acyl Carrier Protein] Reductase [NADH] (FAS-II Enoyl ACP Reductase or NADH Dependent 2-Trans-Enoyl ACP Reductase or inhA or EC 1.3.1.9) - Drugs in Development, 2021 SUMMARY Enoyl [Acyl Carrier...

April 2021 30 pages

Enteritis (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Enteritis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Enteritis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Enteritis pipeline landscape. The report provide...

April 2021 30 pages

Enterobacteriaceae Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Enterobacteriaceae Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Enterobacteriaceae Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Ente...

April 2021 95 pages

Enterococcus Faecium Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Enterococcus Faecium Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Enterococcus Faecium Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the...

April 2021 45 pages

Enterococcus Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Enterococcus Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Enterococcus Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Enterococcus Inf...

April 2021 45 pages

Enterovirus Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Enterovirus Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Enterovirus Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Enterovirus Infect...

April 2021 55 pages

Envelope Protein M (Matrix Protein) - Drugs in Development, 2021

US$ 3,000.00

Envelope Protein M (Matrix Protein) - Drugs in Development, 2021 SUMMARY Envelope Protein M (Matrix Protein) - Drugs in Development, 2021 provides in depth analysis on Envelope Protein M (Matrix Prote...

April 2021 30 pages

Ependymoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Ependymoma (Oncology) - Drugs in Development, 2021 SUMMARY Ependymoma (Oncology) - Drugs in Development, 2021 provides an overview of the Ependymoma pipeline landscape. The report provides comprehensi...

April 2021 55 pages

Ephrin Type A Receptor 2 (Epithelial Cell Kinase or Tyrosine Protein Kinase Receptor ECK or EPHA2 or EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

Ephrin Type A Receptor 2 (Epithelial Cell Kinase or Tyrosine Protein Kinase Receptor ECK or EPHA2 or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Ephrin Type A Receptor 2 (Epithelial Cell Kinase...

April 2021 35 pages

Epidermal Growth Factor (EGF) - Drugs in Development, 2021

US$ 3,000.00

Epidermal Growth Factor (EGF) - Drugs in Development, 2021 SUMMARY Epidermal Growth Factor (EGF) - Drugs in Development, 2021 provides in depth analysis on Epidermal Growth Factor (EGF) targeted pipel...

April 2021 35 pages

Epidermal Growth Factor Receptor (EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

Epidermal Growth Factor Receptor (EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Epidermal Growth Factor Receptor (EC 2.7.10.1) - Drugs in Development, 2021 provides in depth analysis on Epidermal...

April 2021 35 pages

Epileptic Encephalopathy (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Epileptic Encephalopathy (Central Nervous System) - Drugs in Development, 2021 SUMMARY Epileptic Encephalopathy (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Epilep...

April 2021 40 pages

Epithelial Ovarian Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Epithelial Ovarian Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Epithelial Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Epithelial Ovarian Cancer pipeli...

April 2021 300 pages

Epithelial Sodium Channel (ENaC or SCNN1) - Drugs in Development, 2021

US$ 3,000.00

Epithelial Sodium Channel (ENaC or SCNN1) - Drugs in Development, 2021 SUMMARY Epithelial Sodium Channel (ENaC or SCNN1) - Drugs in Development, 2021 provides in depth analysis on Epithelial Sodium Ch...

April 2021 40 pages

Filters

Clear all